<DOC>
	<DOCNO>NCT00417014</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , chlorambucil , vinblastine , procarbazine , prednisolone , work different way stop growth cancer cell , either kill cell stop divide . Radiation therapy use high-energy x-ray kill cancer cell . Giving one drug ( combination chemotherapy ) together radiation therapy may kill cancer cell . PURPOSE : This clinical trial study well give combination chemotherapy and/or radiation therapy work treat young patient Hodgkin 's lymphoma .</brief_summary>
	<brief_title>Combination Chemotherapy and/or Radiation Therapy Treating Young Patients With Hodgkin 's Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : - Establish uniform practice management child Hodgkin 's lymphoma . - Document long-term side effect management . - Establish whether child safely manage without stag laparotomy splenectomy . - Establish whether chlorambucil , vinblastine , procarbazine hydrochloride , prednisolone ( CLVPP ) effective alternative mechlorethamine , vincristine , procarbazine hydrochloride , prednisone ( MOPP ) chemotherapy . OUTLINE : This multicenter study . Patients assign 1 3 treatment regimen accord disease stage presence bulky mediastinal disease . - Involved-field radiotherapy ( patient stage IA [ nodal ] disease ) : Patients undergo involved-field radiotherapy 5 day week 4 week . - CLVPP chemotherapy ( patient stag disease AND bulky mediastinal disease ) : Patients receive CLVPP chemotherapy comprise oral chlorambucil , oral procarbazine hydrochloride , oral prednisolone day 1-14 vinblastine IV day 1 8 . Treatment repeat every 28 day 8 course absence disease progression unacceptable toxicity . - CLVPP chemotherapy radiotherapy ( patient stag disease AND bulky mediastinal disease ) : Patients receive CLVPP chemotherapy . Patients undergo radiotherapy mediastinum begin 2 week complete last course CLVPP chemotherapy . After completion study treatment , patient follow periodically . PROJECTED ACCRUAL : A total 358 patient accrue study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Procarbazine</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<mesh_term>Chlorambucil</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Biopsy prove Hodgkin 's lymphoma Any stage allow PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>stage I childhood Hodgkin lymphoma</keyword>
	<keyword>stage II childhood Hodgkin lymphoma</keyword>
	<keyword>stage III childhood Hodgkin lymphoma</keyword>
	<keyword>stage IV childhood Hodgkin lymphoma</keyword>
	<keyword>recurrent/refractory childhood Hodgkin lymphoma</keyword>
</DOC>